Last reviewed · How we verify
NCT06908811: IOV
Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations
NA trial testing Novel Plant Protein Blend in Resistance Exercise in 60 participants. Completed in 17 January 2025.
17 January 2025
Quick facts
| Lead sponsor | Lindenwood University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 19 August 2022 |
| Primary completion | 17 January 2025 |
| Estimated completion | 17 January 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Novel Plant Protein Blend
- Pea/Rice Protein Blend
- Whey Protein
- Carbohydrate Placebo
Conditions studied
- Resistance Exercise — all drugs for Resistance Exercise →
Sponsor
Lindenwood University
Who can join
Adults 18 to 39, any sex, with Resistance Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study seeks to compare the observed changes in resistance training adaptations (strength, performance, body composition, recovery, and lactate responses) after supplementation of isocaloric and isonitrogenous amounts of a novel plant protein formulation against changes observed in a pea/rice plant protein blend, whey protein, and a carbohydrate placebo in healthy resistance-trained men and women between the ages of 18-39.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06908811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Resistance Exercise
Currently open trials in the same condition.
- NCT07444021 — Effect of Resistance Exercise on Energy Balance and Appetite Regulation in Males and Females · NA · recruiting
- NCT07087769 — Optimizing Gait Symmetry After Stroke Using Mechanical Constraints and Sensory Feedback · NA · recruiting
- NCT07070791 — Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer · NA · recruiting
- NCT06205147 — Effects of Elastic Band Resistance Exercise on Muscle Strength and Depression in Hospitalized Elderly. · NA · recruiting
Other Lindenwood University trials
Trials by the same sponsor.
- NCT07387991 — Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms · NA · not yet recruiting
- NCT07388264 — Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes · NA · recruiting
- NCT07310108 — Evaluation of Cordyceps Militaris M2-116-04 for Its Potential Sport and Exercise Nutrition Applications in Healthy Activ · NA · completed
- NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
- NCT07502924 — Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06908811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lindenwood University
- Last refreshed: 3 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06908811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing